Abstract
Testing methods of detecting various cardiac biomarkers play a significant influence in determining and treating cardiac-related conditions and ultimate prognosis. With the increasing global prevalence of cardiac disease, the importance of rapid testing methods in diagnosis and management has grown tremendously. The point-of-care testing (POCT) method is a potential biochemical diagnostic technique that may overcome the issue of delayed laboratory results, particularly in regions with limited access to advanced laboratory equipment or resource-constrained. Point-of-care (POC) diagnostics are also a user-friendly method and may be easily utilised by laboratory personnel and other healthcare professionals with fundamental basic training in remote areas where specialised laboratories may be challenging to access. Another recent development is of various biosensors with incorporation of artificial intelligence (AI) technology to give early test results that may enable immediate clinical decisions, thereby enhancing the patient's health outcomes. This narrative review has been done with the aim of enhancing knowledge for current POCT methods, their diagnostic role in major cardiac ailments, comparison with other standard methods with ongoing clinical trials, and future developments. Information for this review article has been gathered and compiled by searching major databases on the internet with recent clinical trials and assessed on the Scale for the Assessment of Narrative Review Articles (SANRA) to present here. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12055-024-01850-2.